Cargando…
Assessment of Carfilzomib Treatment Response in Lung Transplant Recipients With Antibody-mediated Rejection
Data supporting the use of carfilzomib (CFZ) for treatment of antibody-mediated rejection (AMR) in lung transplantation in combination with plasmapheresis and intravenous immunoglobulin suggest positive outcomes through donor-specific antibody (DSA) depletion or conversion to noncomplement-activatin...
Autores principales: | Pham, Christine, Pierce, Brett J., Nguyen, Duc T., Graviss, Edward A., Huang, Howard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969244/ https://www.ncbi.nlm.nih.gov/pubmed/33748409 http://dx.doi.org/10.1097/TXD.0000000000001131 |
Ejemplares similares
-
Retransplantation Outcomes at a Large Lung Transplantation Program
por: Ren, Dewei, et al.
Publicado: (2018) -
Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
por: Naik, Chetan, et al.
Publicado: (2018) -
Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
por: Hostetler, Haley P., et al.
Publicado: (2021) -
Lung cancer in recipients after lung transplant: single-centre experience and literature review
por: Lashari, Bilal Haider, et al.
Publicado: (2022) -
Detection of Bacterial Colonization in Lung Transplant Recipients Using an Electronic Nose
por: Wijbenga, Nynke, et al.
Publicado: (2023)